These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 22894615)

  • 81. Origin and impact of plasmid-mediated extended-spectrum beta-lactamases.
    Philippon A; Arlet G; Lagrange PH
    Eur J Clin Microbiol Infect Dis; 1994; 13 Suppl 1():S17-29. PubMed ID: 7821300
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Gram-negative resistance in Singapore: a historical perspective.
    Koh TH
    Ann Acad Med Singap; 2008 Oct; 37(10):847-54. PubMed ID: 19037519
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control.
    Stürenburg E; Mack D
    J Infect; 2003 Nov; 47(4):273-95. PubMed ID: 14556752
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Type I beta-lactamases of gram-negative bacteria: interactions with beta-lactam antibiotics.
    Sanders CC; Sanders WE
    J Infect Dis; 1986 Nov; 154(5):792-800. PubMed ID: 3490520
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Multidrug-resistant Gram-negative bacterial infections: are you ready for the challenge?
    Curcio D
    Curr Clin Pharmacol; 2014 Feb; 9(1):27-38. PubMed ID: 23489027
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Structural and Functional Aspects of Class A Carbapenemases.
    Naas T; Dortet L; Iorga BI
    Curr Drug Targets; 2016; 17(9):1006-28. PubMed ID: 26960341
    [TBL] [Abstract][Full Text] [Related]  

  • 87. beta-Lactamases of gram-negative bacteria: new challenges for new drugs.
    Sanders CC
    Clin Infect Dis; 1992 May; 14(5):1089-99. PubMed ID: 1600011
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Epidemiology of β-Lactamase-Producing Pathogens.
    Bush K; Bradford PA
    Clin Microbiol Rev; 2020 Mar; 33(2):. PubMed ID: 32102899
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Genetic diversity and risk factors for the transmission of antimicrobial resistance across human, animals and environmental compartments in East Africa: a review.
    Katale BZ; Misinzo G; Mshana SE; Chiyangi H; Campino S; Clark TG; Good L; Rweyemamu MM; Matee MI
    Antimicrob Resist Infect Control; 2020 Aug; 9(1):127. PubMed ID: 32762743
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Estimating the association between antibiotic exposure and colonization with extended-spectrum β-lactamase-producing Gram-negative bacteria using machine learning methods: a multicentre, prospective cohort study.
    Tacconelli E; Górska A; De Angelis G; Lammens C; Restuccia G; Schrenzel J; Huson DH; Carević B; Preoţescu L; Carmeli Y; Kazma M; Spanu T; Carrara E; Malhotra-Kumar S; Gladstone BP
    Clin Microbiol Infect; 2020 Jan; 26(1):87-94. PubMed ID: 31128285
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Selection of naturally occurring extended-spectrum TEM beta-lactamase variants by fluctuating beta-lactam pressure.
    Blazquez J; Morosini MI; Negri MC; Baquero F
    Antimicrob Agents Chemother; 2000 Aug; 44(8):2182-4. PubMed ID: 10898697
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Beta-lactamases: a survey of protein diversity.
    Helfand MS; Bonomo RA
    Curr Drug Targets Infect Disord; 2003 Mar; 3(1):9-23. PubMed ID: 12570729
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Updated functional classification of beta-lactamases.
    Bush K; Jacoby GA
    Antimicrob Agents Chemother; 2010 Mar; 54(3):969-76. PubMed ID: 19995920
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Distribution and molecular characterization of beta-lactamases in Gram-negative bacteria in Colombia, 2001-2016.
    Rada AM; Hernández-Gómez C; Restrepo E; Villegas MV
    Biomedica; 2019 May; 39(s1):199-220. PubMed ID: 31529860
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Mechanisms of resistance to beta-lactam antibiotics.
    Livermore DM
    Scand J Infect Dis Suppl; 1991; 78():7-16. PubMed ID: 1947825
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Accuracy of microdilution and the AutoMicrobic System in detection of beta-lactam resistance in gram-negative bacterial mutants with derepressed beta-lactamase.
    Washington JA; Knapp CC; Sanders CC
    Rev Infect Dis; 1988; 10(4):824-9. PubMed ID: 3263689
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Structural and Mechanistic Basis for Extended-Spectrum Drug-Resistance Mutations in Altering the Specificity of TEM, CTX-M, and KPC β-lactamases.
    Palzkill T
    Front Mol Biosci; 2018; 5():16. PubMed ID: 29527530
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Global dissemination of beta-lactamases mediating resistance to cephalosporins and carbapenems.
    Gootz TD
    Expert Rev Anti Infect Ther; 2004 Apr; 2(2):317-27. PubMed ID: 15482196
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Novel beta-lactam antibiotics and inhibitor combinations.
    Bassetti M; Righi E; Viscoli C
    Expert Opin Investig Drugs; 2008 Mar; 17(3):285-96. PubMed ID: 18321228
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Molecular analysis of beta-lactamase structure and function.
    Majiduddin FK; Materon IC; Palzkill TG
    Int J Med Microbiol; 2002 Jul; 292(2):127-37. PubMed ID: 12195735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.